Project Grant R43DE035036
- The National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121), awarded Rytek Medical Inc. a $220,000 Project Grant on August 1, 2025. The grant supports research to evaluate CT/X-ray imaging-correlated impedance-based metrics for predicting surgical osseointegration and injury prevention in dental implant procedures. The project aims to develop innovative diagnostic technologies, such as an impedance-based...
- The Project Grant awarded by the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121), provides $306,633 to Ther-Ai LLC to develop CRANIAMAP, a foundational software module that enhances auto-segmentation and landmarking capabilities for cone beam computed tomography (CBCT) scans. This SBIR Phase I project aims to outperform existing AI-based tools, achieving at least 90% accuracy in segmenting critical...
- This $672,394.58 project grant from the National Institutes of Health's National Institute of Dental and Craniofacial Research Oral Diseases and Disorders Research program (CFDA 93.121) supports the development of a crosslinkable tissue particle implant for regenerating craniofacial bone. Led by Leefa Biotech LLC, the one-year award aims to demonstrate improved bone regeneration in critical-size cranial bone defects using the implant compared to the current standard of care. If successful, the...
- The federal Project Grant award in the amount of $613,736 was provided by the National Institute of Dental and Craniofacial Research (NIDCR), which administers the Oral Diseases and Disorders Research federal grant program (CFDA 93.121). The grant was awarded to Cayman Chemical Co Inc., a for-profit company located in Ann Arbor, Michigan, to develop novel osteogenic small-molecule pharmacotherapies for dental bone regeneration. Specifically, Cayman Chemical will create novel EZH2 inhibitor...
- This Project Grant, awarded by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121), supports research to develop a novel 3D-printed mineral framework and cryogel scaffold to improve bone regeneration in head and neck cancer patients suffering from radiation-induced osteoradionecrosis. The $533,675 grant, with a performance period from July 1, 2025 to March 31, 2030, aims to test the central...
- The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $150,989 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to the Research Foundation for the State University of New York (RFSUNY), doing business as Stony Brook University. The grant aims to develop an automated tool to detect and characterize arterial calcifications in dental cone beam computed tomography (CBCT) scans, which can be indicative of cardiovascular disease. This research...
- The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $1,952,000 Project Grant under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121) to Matregenix Inc., a small disadvantaged business located in California. The grant supports the development of MATRINOVA, an animal-free, amino acid-based biodegradable barrier membrane for guided bone regeneration in dental and craniomaxillofacial surgeries. The research aims to create a membrane with a unique...
- The National Science Foundation awarded a $254,360 Project Grant to Quiver Dental, Inc. under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a diagnostic device to measure dental implant stability. The one-year award running from August 1, 2022 to July 31, 2023 aims to complete proof-of-concept demonstration of a reliable and accurate device using vibrational technology to quantify the degree of motion and stability between a dental implant and surrounding...
- This $27,030 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research (CFDA 93.121) program, supports research to understand how biofilm formation and adhesion is affected by 3D-printed titanium surfaces used in dental implants. The key objectives are to develop experimental tools for measuring structural, deformation, and diffusive properties of single and multi-species oral biofilms on 3D-printed titanium...
- The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $294,632 Project Grant under the Oral Diseases and Disorders Research (CFDA 93.121) program to Greenmark Biomedical Inc. in East Lansing, Michigan. The project aims to develop an intraoral imaging system that uses targeted nanoparticle-enhanced fluorescent technology and artificial intelligence (AI) algorithms to improve early detection and monitoring of dental caries (tooth decay). Specifically, the project involves...
The $296,171 Project Grant awarded on August 8, 2025 by the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), aims to design and evaluate an impedance-based bone assessment technology for characterizing trabecular bone microarchitecture. This technology is intended to address the limitations of current imaging techniques, like cone beam CT, in accurately quantifying bone quality, particularly in the trabecular bone, which is critical for dental implant osseointegration and stability. The grant recipient, Rytek Medical Inc., is a for-profit company based in Lebanon, New Hampshire that specializes in developing innovative medical diagnostic and assessment technologies, with a focus on solutions for dental implants, bone health, and muscle condition assessment.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $296.2k | 8/7/25 |